 Lisa Davis
Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Rheumatoid | 9 | 2018 | 1002 | 1.000 |
Why?
| | Antirheumatic Agents | 3 | 2018 | 255 | 0.510 |
Why?
| | Methotrexate | 2 | 2018 | 228 | 0.430 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2013 | 34 | 0.430 |
Why?
| | Rheumatology | 2 | 2020 | 89 | 0.360 |
Why?
| | Lipids | 1 | 2014 | 582 | 0.360 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2010 | 79 | 0.340 |
Why?
| | Efficiency, Organizational | 1 | 2010 | 126 | 0.330 |
Why?
| | Workflow | 1 | 2010 | 135 | 0.330 |
Why?
| | Registries | 7 | 2017 | 1760 | 0.290 |
Why?
| | Cardiovascular Diseases | 4 | 2017 | 1729 | 0.280 |
Why?
| | Veterans Health | 3 | 2017 | 165 | 0.270 |
Why?
| | Ambulatory Care | 1 | 2010 | 479 | 0.270 |
Why?
| | Physician-Patient Relations | 1 | 2010 | 463 | 0.260 |
Why?
| | Health Literacy | 2 | 2020 | 164 | 0.250 |
Why?
| | Severity of Illness Index | 6 | 2015 | 2542 | 0.250 |
Why?
| | Decision Support Systems, Management | 2 | 2015 | 6 | 0.240 |
Why?
| | Body Mass Index | 4 | 2017 | 1961 | 0.240 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2015 | 243 | 0.200 |
Why?
| | Osteoporosis | 2 | 2014 | 225 | 0.190 |
Why?
| | Glucocorticoids | 2 | 2015 | 534 | 0.180 |
Why?
| | Rheumatic Diseases | 1 | 2020 | 49 | 0.170 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 250 | 0.160 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2014 | 1893 | 0.130 |
Why?
| | Aged, 80 and over | 6 | 2016 | 6364 | 0.120 |
Why?
| | Middle Aged | 10 | 2018 | 26806 | 0.120 |
Why?
| | Genes, rel | 1 | 2014 | 4 | 0.120 |
Why?
| | Spondylarthritis | 1 | 2015 | 36 | 0.120 |
Why?
| | Lipoproteins, HDL | 1 | 2014 | 76 | 0.110 |
Why?
| | Hand | 1 | 2015 | 134 | 0.110 |
Why?
| | Visual Analog Scale | 1 | 2013 | 31 | 0.110 |
Why?
| | Lipoproteins, LDL | 1 | 2014 | 128 | 0.110 |
Why?
| | Aged | 10 | 2018 | 19122 | 0.110 |
Why?
| | Diphosphonates | 1 | 2014 | 51 | 0.110 |
Why?
| | Thrombectomy | 1 | 2013 | 52 | 0.110 |
Why?
| | Vascular Calcification | 1 | 2015 | 107 | 0.110 |
Why?
| | Femoral Fractures | 1 | 2014 | 67 | 0.110 |
Why?
| | Disability Evaluation | 1 | 2015 | 271 | 0.110 |
Why?
| | Risk Factors | 6 | 2017 | 8637 | 0.110 |
Why?
| | Obesity | 2 | 2017 | 2514 | 0.110 |
Why?
| | Weight Loss | 1 | 2017 | 642 | 0.110 |
Why?
| | Symptom Assessment | 1 | 2013 | 118 | 0.100 |
Why?
| | Spinal Fractures | 1 | 2014 | 76 | 0.100 |
Why?
| | Pharmacists | 1 | 2015 | 236 | 0.100 |
Why?
| | Dyslipidemias | 1 | 2014 | 154 | 0.100 |
Why?
| | Joints | 1 | 2013 | 84 | 0.100 |
Why?
| | Triglycerides | 1 | 2014 | 470 | 0.100 |
Why?
| | Cross-Sectional Studies | 4 | 2015 | 4407 | 0.100 |
Why?
| | Male | 12 | 2018 | 55663 | 0.090 |
Why?
| | Time Factors | 4 | 2017 | 6125 | 0.090 |
Why?
| | Brain Ischemia | 1 | 2013 | 299 | 0.090 |
Why?
| | Hypertension | 1 | 2018 | 1059 | 0.090 |
Why?
| | Health Status | 1 | 2015 | 721 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 2 | 2015 | 1177 | 0.080 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 1801 | 0.080 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 934 | 0.080 |
Why?
| | Humans | 16 | 2020 | 114937 | 0.080 |
Why?
| | Cytokines | 1 | 2016 | 1843 | 0.080 |
Why?
| | Neoplasms | 3 | 2017 | 2106 | 0.080 |
Why?
| | Female | 10 | 2018 | 59581 | 0.080 |
Why?
| | Genotype | 1 | 2013 | 1775 | 0.080 |
Why?
| | Research Design | 1 | 2013 | 932 | 0.070 |
Why?
| | Biomarkers | 2 | 2015 | 3418 | 0.070 |
Why?
| | Autoantibodies | 1 | 2015 | 1354 | 0.070 |
Why?
| | United States Department of Veterans Affairs | 3 | 2016 | 557 | 0.070 |
Why?
| | Diabetes Mellitus | 1 | 2015 | 904 | 0.070 |
Why?
| | Myocardial Infarction | 1 | 2014 | 929 | 0.070 |
Why?
| | Surveys and Questionnaires | 2 | 2015 | 4635 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2014 | 2102 | 0.070 |
Why?
| | Veterans | 2 | 2014 | 1240 | 0.060 |
Why?
| | Respiratory Tract Diseases | 2 | 2017 | 140 | 0.060 |
Why?
| | Stroke | 1 | 2013 | 1019 | 0.060 |
Why?
| | Cause of Death | 2 | 2017 | 363 | 0.060 |
Why?
| | Peptides, Cyclic | 2 | 2016 | 254 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2016 | 1080 | 0.050 |
Why?
| | Risk Assessment | 3 | 2017 | 2975 | 0.050 |
Why?
| | United States | 5 | 2017 | 12211 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2016 | 1440 | 0.050 |
Why?
| | Follow-Up Studies | 1 | 2010 | 4427 | 0.050 |
Why?
| | Comorbidity | 2 | 2016 | 1458 | 0.040 |
Why?
| | Adult | 4 | 2015 | 30608 | 0.040 |
Why?
| | Incidence | 2 | 2018 | 2316 | 0.040 |
Why?
| | Sex Factors | 2 | 2016 | 1721 | 0.040 |
Why?
| | Prospective Studies | 1 | 2010 | 6218 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2016 | 2382 | 0.040 |
Why?
| | Sulfasalazine | 1 | 2018 | 21 | 0.040 |
Why?
| | Hydroxychloroquine | 1 | 2018 | 55 | 0.040 |
Why?
| | Electronic Health Records | 2 | 2015 | 802 | 0.040 |
Why?
| | Prognosis | 2 | 2016 | 3344 | 0.040 |
Why?
| | Prednisone | 1 | 2018 | 231 | 0.040 |
Why?
| | Rheumatic Nodule | 1 | 2016 | 3 | 0.030 |
Why?
| | Thinness | 1 | 2016 | 87 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 770 | 0.030 |
Why?
| | Rheumatoid Factor | 1 | 2016 | 157 | 0.030 |
Why?
| | Lymphoma | 1 | 2016 | 177 | 0.030 |
Why?
| | Chemokines | 1 | 2016 | 213 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2015 | 80 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 2018 | 451 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2016 | 362 | 0.030 |
Why?
| | Leukemia | 1 | 2016 | 210 | 0.030 |
Why?
| | Interleukin-4 | 1 | 2015 | 208 | 0.030 |
Why?
| | Causality | 1 | 2014 | 105 | 0.030 |
Why?
| | Life Style | 1 | 2016 | 430 | 0.030 |
Why?
| | Bone Density Conservation Agents | 1 | 2014 | 61 | 0.030 |
Why?
| | Thrombolytic Therapy | 1 | 2013 | 117 | 0.030 |
Why?
| | Radiography | 1 | 2015 | 819 | 0.030 |
Why?
| | Health Services Research | 1 | 2015 | 371 | 0.030 |
Why?
| | Blood Pressure | 1 | 2018 | 1537 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2013 | 233 | 0.020 |
Why?
| | Survival Rate | 1 | 2015 | 1644 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1220 | 0.020 |
Why?
| | Logistic Models | 1 | 2015 | 1844 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2018 | 12544 | 0.020 |
Why?
| | Pancreatic Neoplasms | 1 | 2016 | 733 | 0.020 |
Why?
| | Pilot Projects | 1 | 2014 | 1372 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 2016 | 925 | 0.020 |
Why?
| | Smoking | 1 | 2016 | 1391 | 0.020 |
Why?
| | Databases, Factual | 1 | 2014 | 1125 | 0.020 |
Why?
| | Health Personnel | 1 | 2014 | 574 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1700 | 0.020 |
Why?
| | Chronic Disease | 1 | 2014 | 1593 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 2770 | 0.020 |
Why?
| | Age Factors | 1 | 2014 | 2891 | 0.020 |
Why?
| | Cohort Studies | 1 | 2014 | 4903 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2016 | 2223 | 0.010 |
Why?
| | Young Adult | 1 | 2013 | 10478 | 0.010 |
Why?
| | Adolescent | 1 | 2013 | 17829 | 0.010 |
Why?
|
|
Davis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|